424B5The Raise
Revolution Medicines, Inc. files 424B5
Filed Apr 13, 2026 · 2mo ago · Accession 0001193125-26-152972
Plain English
This filing is a prospectus supplement for Revolution Medicines, Inc. offering $250,000,000 in convertible senior notes due 2033. The company intends to use the proceeds for general corporate purposes, including research and development.
Filing details
- Company
- Revolution Medicines, Inc.
- Ticker
- RVMD
- CIK
- 1628171
- Form type
- 424B5
- Filing date
- Apr 13, 2026
- Report date
- —
- Document
- d124966d424b5.htm
- Size
- 1.1 MB